1). Hu RL, Huang G, Qiu W, Zhong ZH, Xia XZ, Yin Z. Detection and differentiation of CAV-1 and CAV-2 by polymerase chain reaction. Vet Res Commun. 2001; 25:77–84.
2). Timurkan MO, Aydin H, Alkan F. Detection and molecular characterization of canine adenovirus type 2 (CAV-2) in dogs with respiratory tract symptoms in shelters in Turkey. Veterinarski arhiv. 2018; 88:467–79.
3). Liu YC, Abouhaidar MG, Sira S, Campbell JB. Characterization of the genome of a vaccine strain of canine adenovirus type 1.
Virus Genes. 1988; 2:69–81.
Article
4). Russell WC. Adenoviruses: update on structure and function.
J Gen Virol. 2009; 90:1–20.
Article
5). Walker D, Abbondati E, Cox AL, Mitchell GB, Pizzi R, Sharp CP, et al. Infectious canine hepatitis in red foxes (Vulpes vulpes) in wildlife rescue centres in the UK. Vet Rec. 2016; 178:421.
6). Buonavoglia C, Martella V. Canine respiratory viruses.
Vet Res. 2007; 38:355–73.
Article
7). Choi JW, Lee HK, Kim SH, Kim YH, Lee KK, Lee MH, et al. Canine adenovirus type 1 in a fennec fox (Vulpes zerda).
J Zoo Wildl Med. 2014; 45:947–50.
Article
8). Cabasso VJ. Infectious canine hepatitis virus. Ann N Y Acad Sci. 1962; 101:498–514.
9). Wong M, Woolford L, Hasan NH, Hemmatzadeh F. A Novel Recombinant Canine Adenovirus Type 1 Detected from Acute Lethal Cases of Infectious Canine Hepatitis.
Viral Immunol. 2017; 30:258–63.
Article
10). Yang DK, Kim HH, Yoon SS, Ji M, Cho IS. Incidence and Sero-survey of Canine Adenovirus Type 2 in Various Animal Species. J Bacteriol Virol. 2018; 48:102–8.
Article
11). Marusyk RG, Yamamoto T. Characterization of a canine adenovirus hemagglutinin.
Can J Microbiol. 1971; 17:151–5.
Article
12). Noon KF, Rogul M, Binn LN, Keefe TJ, Marchwicki RH, Thomas R, et al. An enzyme-linked immunosorbent assay for the detection of canine antibodies to canine adenoviruses. Lab Anim Sci. 1979; 29:603–9.
13). Segura MM, Puig M, Monfar M, Chilló n M. Chromatography purification of canine adenoviral vectors.
Hum Gene Ther Methods. 2012; 23:182–97.
Article
14). Coronel J, Behrendt I, Bü rgin T, Anderlei T, Sandig V, Reichl U, et al. Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.
Vaccine. 2019; 37:7011–8.
Article
15). Muhamuda K, Madhusudana SN, Ravi V. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
Int J Infect Dis. 2007; 11:441–5.
Article
16). Gschwender HH, Brummund M, Lehmann-Grube F. Lymphocytic Choriomeningitis virus. I. Concentration and purification of the infectious virus.
J Virol. 1975; 15:1317–22.
Article
17). Schagen FH, Rademaker HJ, Rabelink MJ, van Ormondt H, Fallaux FJ, van der Eb AJ, et al. Ammonium sulphate precipitation of recombinant adenovirus from culture medium: an easy method to increase the total virus yield.
Gene Ther. 2000; 7:1570–4.
Article
18). Kanegae Y, Makimura M, Saito I. A simple and efficient method for purification of infectious recombinant adenovirus.
Jpn J Med Sci Biol. 1994; 47:157–66.
Article
19). Yang DK, Kim HH, Lee SH, Ji M, Cho IS. Indirect ELISA for the Detection of Rabies Virus Antibodies in Dog Sera.
J Bacteriol Virol. 2017; 47:148–55.
Article
20). Burova E, Ioffe E. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications.
Gene Ther. 2005; 12(Suppl 1):S5–17.
Article
21). Konz JO, Livingood RC, Bett AJ, Goerke AR, Laska ME, Sagar SL. Serotype specificity of adenovirus purification using anion-exchange chromatography.
Hum Gene Ther. 2005; 16:1346–53.
Article
22). Zhu M, Carta G. Protein adsorption equilibrium and kinetics in multimodal cation exchange resins.
Adsorption. 2016; 22:165–79.
Article
23). He Y, Gao D, Zhang M. Expression of the nucleoprotein gene of rabies virus for use as a diagnostic reagent.
J Virol Methods. 2006; 138:147–51.
Article